China Medical System Holdings Ltd
00867
Company Profile
Business description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
Contact
510 King’s Road
Unit 2106, 21st Floor, Island Place Tower
North Point
Hong Kong
HKGT: +852 23697678
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
6,415
Stocks News & Analysis
stocks
Avoid this overvalued ASX lithium producer
Why the market may be overpricing future earnings for this lithium producer.
stocks
Morningstar's verdict on SpaceX
Mark and Shani run through the business and what our analysts think about the IPO.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,994.70 | 7.20 | -0.08% |
| CAC 40 | 8,340.71 | 59.40 | -0.71% |
| DAX 40 | 24,893.58 | 246.11 | -0.98% |
| Dow JONES (US) | 51,666.84 | 45.87 | -0.09% |
| FTSE 100 | 10,428.85 | 9.00 | -0.09% |
| HKSE | 23,344.67 | 8.39 | 0.04% |
| NASDAQ | 25,587.04 | 579.56 | -2.21% |
| Nikkei 225 | 68,980.21 | 808.17 | -1.16% |
| NZX 50 Index | 13,382.87 | 52.90 | -0.39% |
| S&P 500 | 7,365.46 | 107.33 | -1.44% |
| S&P/ASX 200 | 8,793.00 | 8.40 | -0.10% |
| SSE Composite Index | 4,096.14 | 10.11 | -0.25% |